Related Experiment Video
Updated: Jan 4, 2026

11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
5.2K
Kidney-based in vitro models for drug-induced toxicity testing.
João Faria1, Sabbir Ahmed1, Karin G F Gerritsen2
1Division of Pharmacology, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands.
Archives of Toxicology
|October 31, 2019
Summary
Predicting drug-induced kidney damage is vital for safe drug development. Current methods fail to capture the kidney
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Kidney damage from drugs (drug-induced nephrotoxicity) is a significant issue in pharmacotherapy, accounting for up to 25% of serious adverse effects.
- Antimicrobials are a notable cause, contributing to one-third of these drug-induced kidney injuries.
- Existing in vitro assays often fail to predict in vivo toxicity due to inadequate models of the kidney's complex microenvironment.
Purpose of the Study:
- To review drug-induced kidney injuries.
- To detail relevant and translational biomarkers for assessing nephrotoxicity.
- To discuss advancements in 3D human renal cell cultures for improved toxicity prediction.
Main Methods:
- Literature review of drug-induced nephrotoxicity.
- Analysis of existing in vitro assay limitations.
- Exploration of novel 3D cell culture models like organoids and kidney-on-a-chip platforms.
Main Results:
- Drug-induced nephrotoxicity mechanisms include direct cellular damage, vascular effects, and crystal deposition.
- The kidney's complex microenvironment, including cell polarity and intercellular communication, is critical for predicting toxic responses.
- 3D culture models show promise in better replicating the in vivo kidney microenvironment.
Conclusions:
- Accurate prediction of drug-induced kidney injury requires models that preserve the kidney's microenvironment.
- Advancements in 3D renal cell cultures offer improved platforms for drug nephrotoxicity screening.
- Further research into biomarkers and advanced models is essential for developing safer drugs.
Related Concept Videos
In Vitro Drug Dissolution: Compendial Testing Models I
179
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
179
In Vitro Drug Dissolution: Compendial Testing Models II
193
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
193
Acute Kidney Injury IV: Diagnostic Studies and Prevention
231
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
231

